Berkeley / Haas - 09-21-2022 | Clear Admit ApplyWire

<< Back to ApplyWire

September 21, 2022 4:48am ET

Applying: Berkeley / Haas, Columbia, Harvard Business School, MIT Sloan, Stanford GSB, U. Chicago Booth, UPenn / Wharton

Intake Year: 2023

Pre-MBA Career: Life Sciences Consulting

Post-MBA Target Industry: Investment Banking, Pharmaceutical

GMAT: 740

GPA: 3.52

Years of Work Experience: 4

Notes:

Slightly low GPA relative to class averages. Working at a boutique biotech consulting firm - very strong career progression and great LOR (hoping this makes up for lack of brand name firm)

Like (0)

Show Comments (4) Last: September 27, 2022

alexbr4 Verified User. Likes Earned: 1678 Be good to know more about your post MBA goals? Super GMAT should help with the slightly lower GPA. Are you involved in activities outside of work? Kellogg might also be worth exploring. Are you focusing on Round 2? (0)

anon16038 Likes Earned: 4 Looking to go into investment banking or healthcare PE (1)

alexbr4 Verified User. Likes Earned: 1678 IB might be a good segue to PE, which is notoriously difficult to access. (0)

grichmond Verified User. Likes Earned: 1245 IB will be a big pivot from your current path, but I get it if you are hoping to push for PE roles. To what extent will banks like your undergrad transcript? Will they find evidence of quantitative coursework there? Does the consulting work you presently perform involve a fair amount of modeling? These little elements could help make the case for the transition you are looking to make. Rec letter will help, as long as referee knows their stuff/has been properly coached by you to understand the process/what schools seek. Wharton might offer a powerful combination of healthcare management course offerings and finance chops to get you where you want to go; I'd reach out to the head of their HCM program and have a conversation. Best of luck!
(1)